Inventor

Stuart A. Aaronson

Inventor

Great Falls, VA, US

Overview

1989–2014

Patent span

Chemistry

Primary field (CPC C)

Patents· 42 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary

C07KPeptides27%

A61KPreparations for medical, dental or toiletry purposes24%

G01NInvestigating or analysing materials by determining their chemical or physical properties13%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations10%

C12NMicroorganisms or enzymes8%

C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms7%

Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests5%

Y02ATechnologies for adaptation to climate change3%

A01KAnimal husbandry1%

Y10TTechnical subjects covered by former us classification1%

PatentTitleYear

8,809,287'Compositions and methods for altering Wnt autocrine signaling'2014 7,838,216'Human gene related to but distinct from EGF receptor gene'2010 7,605,127'Truncated hepatocyte growth factor variant protein HGF/NK2'2009 7,427,671'Compositions of alpha platelet derived growth factor receptor nucleic acid and protein and method of making'2008 7,252,929'Methods for identifying alpha PDGFR agonists and antagonists'2007 7,183,377'Human FRP and fragments thereof including methods for using them'2007 7,026,291'Epithelial cell specific growth factor, keratinocyte growth factor (KGF)'2006 6,833,132'Method of stimulating epithelial cells using keratinocyte growth factor (KGF) and method of inhibiting KGF activity'2004 6,709,842'DNA encoding a growth factor specific for epithelial cells'2004 6,660,488'Antibodies for the alpha platelet-derived growth factor receptor'2003 6,653,084'Anti-erbB-2 antibodies to human receptor related to but distinct from EGF receptor'2003 6,639,060'erbB-3 nucleic acids'2003 6,566,098'DNA encoding truncated hepatocyte growth factor variants'2003 6,479,255'Polynucleotides encoding human FRP and fragments thereof'2002 6,420,531'Epithelial cell specific growth factor, keratinocyte growth factor (KGF)'2002 6,403,769'Fusion proteins that include antibody and nonantibody portions'2002 6,228,600'Immunoassays for the alpha platelet-derived growth factor receptor'2001 6,225,088'DNA encoding plasminogen-like growth factor (PLGF) and related embodiments'2001 5,985,553'erbB-2 gene segments, probes, recombinant DNA and kits for detection'1999 5,965,359'Method of detecting the expression of alpha platelet-derived growth factor receptor gene'1999 5,916,755'Methods of characterizing ligands for the erbB-3 receptor, methods of influencing erbB-3 activities and methods of diagnosing erbB-3-related neoplasm'1999 5,863,739'Assay and kit for the detection of .alpha. platelet derived growth factor receptor'1999 5,833,986'Methods of inhibiting the growth of neoplasia using a monoclonal antibody against .alpha. platelet derived growth factor receptor'1998 5,820,859'Method of targeting a therapeutic agent to cells expressing the erb B-3 receptor'1998 5,821,223'Method of stimulating cell growth with a novel broad spectrum human lung fibroblast-derived mitogen'1998 5,792,638'Human ras-related oncogenes unmasked by expression cDNA cloning'1998 5,747,261'Protein related to but distinct from EGF receptor and antibodies reactive therewith'1998 5,741,642'Assay for detecting the expression of a gene encoding human keratinocyte growth factor (KGF)'1998 5,731,170'DNA encoding a growth factor specific for epithelial cells'1998 5,707,805'Assay for detecting keratinocyte growth factor (KGF) and its activity'1998 5,693,778'Arg a human gene related to but distinct from abl proto-oncogene'1997 5,665,870'Method of purifying keratinocyte growth factor (KGF)'1997 5,654,405'Antbodies to human kerctinocyte growth factor (KGF) and related pharmaceuticals'1997 5,648,273'Hepatic growth factor receptor is the MET proto-oncogene'1997 5,595,895'Efficient directional genetic cloning system'1997 5,578,566'KGF receptor-derived antagonists of KGF binding'1996 5,573,935'Protein tyrosine kinase A6'1996 5,512,434'Expression cloning of a human phosphatase'1996 5,480,968'Isolated polypeptide erbB-3, related to the epidermal growth factor receptor and antibody thereto'1996 5,468,468'Method for making a monoclonal antibody, monoclonal antibodies to .alpha. P D'1995 5,183,884'DNA segment encoding a gene for a receptor related to the epidermal growth factor receptor'1993 4,820,631'Deletion mutants and monoclonal antibodies against ras proteins'1989

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1989–2009Patents assigned to US HEALTH (29)· patent assignee history

1989–2003Based in Vienna, VA, US· patent location history

1995–2010Based in Great Falls, VA, US· patent location history

1996–1998Patents assigned to US ARMY (10)· patent assignee history

1998–2014Based in New York, NY, US· patent location history

2014Patents assigned to AARONSON STUART (1)· patent assignee history

2014Patents assigned to BAFICO ANNA (1)· patent assignee history

2014Patents assigned to ICAHN SCHOOL MED MOUNT SINAI (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
US HEALTH	29	1989–2009
US ARMY	10	1996–1998
AARONSON STUARTself	1	2014
BAFICO ANNA	1	2014
ICAHN SCHOOL MED MOUNT SINAI	1	2014

Locations

Location	Patents	Span
Great Falls, Virginia, US	24	1995–2010
New York, New York, US	12	1998–2014
Vienna, Virginia, US	6	1989–2003